发明名称 Controlled release formulations of macrolide citrate salts
摘要 <p>Disclosed is an oral controlled release macrolide pharmaceutical formulation. In a preferred embodiment, the formulation comprises a citrate salt of a preferred macrolide, clarithromycin. Also disclosed are methods for preparing, isolating and characterizing soluble and stable citrate salt of macrolides and use thereof in all solid dosage forms of macrolides.</p>
申请公布号 EP1302205(A1) 申请公布日期 2003.04.16
申请号 EP20020256823 申请日期 2002.10.01
申请人 IND-SWIFT LIMITED 发明人 WADHWA, HARDEEP
分类号 C07H17/08;A61K9/14;A61K9/16;A61K9/20;A61K9/22;A61K9/30;A61K9/36;A61K9/48;A61K31/4745;A61K31/70;A61K31/7048;A61K47/00;A61K47/10;A61K47/26;A61K47/30;A61K47/32;A61K47/38;A61P31/00;A61P31/04;(IPC1-7):A61K31/704 主分类号 C07H17/08
代理机构 代理人
主权项
地址